Moleculin Biotech CS (MBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,600 | 11,722 | 13,114 | 7,714 | 8,736 |
| TOTAL | $9,360 | $12,892 | $13,748 | $8,302 | $9,463 |
| Non-Current Assets | |||||
| PPE Net | 391 | 26 | 33 | 33 | 22 |
| Intangibles | 11,148 | 11,148 | 11,148 | 11,148 | 11,148 |
| TOTAL | $11,539 | $11,174 | $11,181 | $11,181 | $11,170 |
| Total Assets | $20,899 | $24,066 | $24,929 | $19,483 | $20,633 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,610 | 3,515 | 1,336 | 1,712 | 1,089 |
| Other current liabilities | 369 | 451 | 463 | 503 | 743 |
| TOTAL | $3,129 | $4,116 | $1,799 | $2,215 | $1,832 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 150 | 150 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 2,710 | 3,202 | 2,410 | 0 | 0 |
| TOTAL | $2,802 | $3,202 | $2,560 | $150 | $150 |
| Total Liabilities | $5,931 | $7,318 | $4,359 | $2,365 | $1,982 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12 | 12 | 11 | 11 | 9 |
| Common Shares | 27 | 27 | 26 | 21 | 21 |
| Retained earnings | -23,571 | -21,532 | -16,407 | -14,480 | -11,295 |
| Other shareholders' equity | 21 | 6 | 0 | 0 | 0 |
| TOTAL | $14,968 | $16,748 | $20,570 | $17,118 | $18,651 |
| Total Liabilities And Equity | $20,899 | $24,066 | $24,929 | $19,483 | $20,633 |